These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3347936)

  • 1. Pharmacokinetics of cyclosporine G in patients with renal failure.
    Wenk M; Bindschedler M; Costa E; Zuber M; Vozeh S; Thiel G; Abisch E; Keller HP; Beveridge T; Follath F
    Transplantation; 1988 Mar; 45(3):558-61. PubMed ID: 3347936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous cyclosporine kinetics in renal failure.
    Follath F; Wenk M; Vozeh S; Thiel G; Brunner F; Loertscher R; Lemaire M; Nussbaumer K; Niederberger W; Wood A
    Clin Pharmacol Ther; 1983 Nov; 34(5):638-43. PubMed ID: 6627824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine kinetics in renal transplant patients as assessed by high-performance liquid chromatography and radioimmunoassay using monoclonal and polyclonal antibodies.
    Speck RF; Frey FJ; Frey BM
    Transplantation; 1989 May; 47(5):802-6. PubMed ID: 2655217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine kinetics in healthy volunteers.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Gray JA; Van Thiel DH; Sanghvi A; Rosenthal JT
    J Clin Pharmacol; 1987 Mar; 27(3):243-8. PubMed ID: 3680581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of cyclosporine A and Nva2-cyclosporine (cyclosporine G) in a rat renal allograft model.
    Grant D; Zhong R; Stiller C; Wallace C; Keown P; Duff J
    Transplantation; 1987 Jul; 44(1):9-12. PubMed ID: 3299927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley rats.
    Duncan JI; Thomson AW; Simpson JG; Davidson RJ; Whiting PH
    Transplantation; 1986 Oct; 42(4):395-9. PubMed ID: 3765053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state concentration of cyclosporin G (OG37-325) and its metabolites in renal transplant recipients.
    Langman LJ; Leichtman AB; Weitzel WF; Yatscoff RW
    Clin Chem; 1994 Apr; 40(4):613-6. PubMed ID: 8149619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cyclosporine assay methodology in the immediate postoperative period of renal transplantation.
    Morse GD; Holdsworth MT; Walshe JJ
    Ther Drug Monit; 1989; 11(3):238-45. PubMed ID: 2658209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine metabolism and pharmacokinetics following intravenous and oral administration in the dog.
    Gridelli B; Scanlon L; Pellicci R; LaPointe R; DeWolf A; Seltman H; Diven W; Shaw B; Starzl T; Sanghvi A
    Transplantation; 1986 Mar; 41(3):388-91. PubMed ID: 3952805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetically determined cyclosporine dosage in young children.
    Hoppu K; Koskimies O; Holmberg C; Hirvisalo EL
    Pediatr Nephrol; 1991 Jan; 5(1):1-4. PubMed ID: 2025515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of cyclosporin G in humans.
    Mangold JB; Schran HF; Tse FL
    Drug Metab Dispos; 1994; 22(6):873-9. PubMed ID: 7895604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of orally and intravenously administered cyclosporine in pre-kidney transplant patients.
    Aweeka FT; Tomlanovich SJ; Prueksaritanont T; Gupta SK; Benet LZ
    J Clin Pharmacol; 1994 Jan; 34(1):60-7. PubMed ID: 8132853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and clinical tolerance of intravenous and oral cyclosporine in the immediate postoperative period.
    Morse GD; Holdsworth MT; Venuto RC; Gerbasi J; Walshe JJ
    Clin Pharmacol Ther; 1988 Dec; 44(6):654-64. PubMed ID: 3058372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and tolerability of cyclosporine G in human kidney transplant recipients.
    Huser B; Thiel G; Oberholzer M; Beveridge T; Bianchi L; Mihatsch MJ; Landmann J
    Transplantation; 1992 Jul; 54(1):65-9. PubMed ID: 1631947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of ketoconazole on the pharmacokinetics of cyclosporine A in cats.
    McAnulty JF; Lensmeyer GL
    Vet Surg; 1999; 28(6):448-55. PubMed ID: 10582742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of less chronic nephrotoxicity by cyclosporine G than cyclosporine A in a low-salt rat model.
    Burdmann EA; Rosen S; Lindsley J; Elzinga L; Andoh T; Bennett WM
    Transplantation; 1993 May; 55(5):963-6. PubMed ID: 8497907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration.
    Gupta SK; Manfro RC; Tomlanovich SJ; Gambertoglio JG; Garovoy MR; Benet LZ
    J Clin Pharmacol; 1990 Jul; 30(7):643-53. PubMed ID: 2391396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine pharmacokinetics in liver transplant recipients: evaluation of results using both polyclonal radioimmunoassay and liquid chromatographic analysis.
    Tredger JM; Grevel J; Naoumov N; Steward CM; Niven AA; Whiting B; Williams R
    Eur J Clin Pharmacol; 1991; 40(5):513-9. PubMed ID: 1884727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that cyclosporine G is less deleterious to rat bone in vivo than cyclosporine A.
    Stein B; Takizawa M; Schlosberg M; Movsowitz C; Fallon M; Berlin JA; Epstein S
    Transplantation; 1992 Mar; 53(3):628-32. PubMed ID: 1549857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays.
    Yatscoff RW; Langman LJ; LeGatt DF
    Clin Chem; 1993 Jun; 39(6):1089-92. PubMed ID: 8504544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.